Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
China · Delayed Price · Currency is CNY 36.20
+0.49 (1.37%)
Sep 14, 2026, 3:04 PM CST
SHE:300573 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,711 | 2,473 | 1,943 | 1,468 | 1,250 | 1,028 |
Revenue Growth | 22.43% | 27.24% | 32.42% | 17.42% | 21.59% | 49.26% |
Gross Profit Gross Profit Growth | 2,217 | 1,995 | 1,519 | 1,127 | 979.78 | 798.91 |
Operating Income Operating Income Growth | 893.82 | 810.48 | 408.42 | 259.93 | 231.2 | 240.31 |
Net Income Net Income Growth | 791.43 | 695.86 | 338.06 | 240.04 | 211.68 | 194.7 |
Earnings Per Share EPS Growth | 2.21 | 1.95 | 0.95 | 0.68 | 0.61 | 0.60 |
EPS Growth | 56.13% | 105.08% | 40.00% | 12.33% | 1.17% | 120.43% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 2,387 | 1,791 | 1,089 | 820.98 | 706.67 |
Medical Service Medical Service Growth | 66.1 | 132.89 | 350.93 | 405.67 | 317.44 |
Unallocated Other Operations Unallocated Other Operations Growth | 19.92 | 19.49 | 27.86 | 23.2 | 3.81 |
Total Total Growth | 2,473 | 1,943 | 1,468 | 1,250 | 1,028 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 466.25 | 393.71 | 370.12 | 480.42 | 515.45 | 686.36 |
Total Debt Total Debt Growth | 59.16 | 82.03 | 215.31 | 79.15 | 13.81 | 111.28 |
Net Cash (Debt) Net Cash Growth | 407.09 | 311.69 | 154.81 | 401.27 | 501.64 | 575.08 |
Net Cash Growth | 110.53% | 101.33% | -61.42% | -20.01% | -12.77% | - |
Net Cash Per Share Net Cash Per Share Growth | 1.14 | 0.87 | 0.44 | 1.14 | 1.43 | 1.77 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 841.29 | 753.39 | 416.98 | 317.57 | 286.26 | 306.96 |
Capital Expenditures CapEx Growth | -243.3 | -270.53 | -198.71 | -261.96 | -299.23 | -95.06 |
Free Cash Flow Free Cash Flow Growth | 597.98 | 482.86 | 218.27 | 55.61 | -12.96 | 211.9 |
Free Cash Flow Growth | 86.89% | 121.22% | 292.54% | - | - | 1412.86% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 81.77% | 80.67% | 78.16% | 76.81% | 78.39% | 77.72% |
Operating Margin | 32.97% | 32.77% | 21.02% | 17.71% | 18.50% | 23.38% |
Pretax Margin | 33.12% | 32.36% | 20.33% | 18.06% | 18.70% | 23.69% |
Profit Margin | 29.19% | 28.14% | 17.39% | 16.36% | 16.94% | 18.94% |
FCF Margin | 22.06% | 19.53% | 11.23% | 3.79% | -1.04% | 20.61% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.172 | 1.172 | 0.739 | 1.302 | 0.377 | 0.163 |
Dividend Per Share Growth | 58.42% | 58.67% | -43.24% | 245.33% | 130.72% | 160.19% |
Dividend Yield | 3.10% | 2.46% | 2.23% | 2.14% | 1.28% | 0.51% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 16.36 | 24.89 | 36.17 | 94.63 | 52.33 | 57.85 |
Forward PE | - | 24.68 | 24.68 | 62.66 | 24.48 | - |
P/FCF Ratio | 21.63 | 35.87 | 56.03 | 408.51 | - | 53.15 |
PS Ratio | 4.77 | 7.01 | 6.29 | 15.48 | 8.86 | 10.96 |